Cost-effectiveness analysis of apixaban compared to low-molecular-weight heparins and Vitamin K antagonists for treatment and secondary prevention of venous thromboembolism

1. Elías, I.
2. Oyagüez, I.
3. Álvarez-Sala, L.A.
4. García-Bragado, F.
5. Navarro, A.
6. González, P.
7. De Andrés-Nogales, F.
8. Soto, J.